Clinical Trials in Austin

Showing 2721-2740 of 7,312 trials

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

NCT03664960

This is a Phase 2, open-label, extension study to assess the safety and tolerability of AK002, given monthly for up to 26 doses.

Eosinophilic GastritisEosinophilic GastroenteritisEosinophilic Duodenitis

Allakos Inc.58 participantsStarted Nov 2018

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Ventura, California, United States +14 more locations

COMPLETED< 1 mile

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

NCT01474811

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Hepatitis C

University of North Carolina, Chapel Hill13,559 participantsStarted Nov 2011

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • La Jolla, California, United States +57 more locations

An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Find Trials by Condition in Austin

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

AuriNovo for Auricular Reconstruction

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Epithelioid Sarcoma Natural History Study

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

OCS Lung System EXPAND II Trial

Cardionomic STOP-ADHF Study

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

DeepView SnapShot Portable (DV-SSP): Device Training Study

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Pilot Prospective Study: Long-term Health of Living Kidney Donors

Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria